| Chimeric antigen receptor-engineered natural killer (CAR NK) cells in cancer treatment; recent advances and future prospects R Elahi, AH Heidary, K Hadiloo, A Esmaeilzadeh Stem Cell Reviews and Reports 17, 2081-2106, 2021 | 53 | 2021 |
| CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy K Hadiloo, S Tahmasebi, A Esmaeilzadeh Cancer Cell International 23 (1), 86, 2023 | 18 | 2023 |
| The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors K Hadiloo, S Taremi, M Heidari, A Esmaeilzadeh Biomarker Research 11 (1), 103, 2023 | 9 | 2023 |
| Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors A Esmaeilzadeh, K Hadiloo, M Jabbari, R Elahi Life Sciences, 122381, 2023 | 7 | 2023 |
| The associations of oxidative stress and inflammatory markers with obesity in Iranian population: MASHAD cohort study H Ghazizadeh, A Mansoori, T Sahranavard, M Nasrabadi, K Hadiloo, ... BMC Endocrine Disorders 24 (1), 56, 2024 | | 2024 |
| The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs K Hadiloo, S Taremi, SH Safa, S Amidifar, A Esmaeilzadeh Pharmacological Research, 107158, 2024 | | 2024 |
Abdolreza EsmaeilzadehProfessor of Medical Immunology, Immunology Dept and Cancer Gene Therapy Research Center, School of在 zums.ac.ir 的电子邮件经过验证
